#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic liposarcoma Neuroblastoma recurrent Hypotransferrinaemia Eosinophilic oesophagitis Heart disease congenital Growth hormone deficiency Aplastic anaemia Arteriosclerosis Vitamin B12 deficiency Extraskeletal ossification Diffuse large B-cell lymphoma recurrent Cervix carcinoma Anaemia Ornithine transcarbamoylase deficiency Extranodal marginal zone B-cell lymphoma (MALT type) More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia refractory – Life with Disease Pelizaeus-Merzbacher disease – Treatment Lymphatic malformation Breast angiosarcoma – Life with Disease Alveolar rhabdomyosarcoma – Basic Information X-linked lymphoproliferative syndrome – Treatment Angiosarcoma – Basic Information Isodicentric chromosome 15 syndrome – Trials in Disease Turner’s syndrome – Diagnostics Langerhans’ cell histiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naxitamab Bi 3720931 Sunvozertinib Propafenone Hydrochloride Naltrexone Hydrochloride Insulin Aspart [18F] CANAGLIFLOZIN MZE829 177LU-FAP-2286 Doxorubicin Vibegron SAR443820 Eptacog Alfa (Activated) TTX-381 Pramipexole Ibrexafungerp Acetylcysteine Amide Letetresgene Autoleucel Interleukin-2 Poa Pratensis Pollen Extract More therapies…

    Learn about Your Condition

    Bronchopulmonary dysplasia Back pain Lennox-Gastaut syndrome Choroidal neovascularisation Febrile neutropenia Varices oesophageal Retinal artery occlusion Neuropathic arthropathy Erdheim-Chester disease Lichen planopilaris Mucopolysaccharidosis Atrophic vulvovaginitis Diphtheria Status epilepticus Hyperphagia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Schizophrenia

  • A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

    Recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • GXV813
    Bulgaria

  • A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

    Recruiting

    3 1
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Romania

  • A study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.

    Recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • HTL0022537
    Bulgaria Croatia Poland Romania

  • A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Brexpiprazole Fumarate
    • Brexpiprazole
    Romania

  • Long-Term Safety Study of Direclidine in Adults with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania

  • A study testing direclidine compared to placebo in adults with schizophrenia who need hospital care

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Hungary Romania
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!